Skip to main content

Table 1 Demographics, symptoms, risk factors

From: Transfemoral versus transapical approach for transcatheter aortic valve implantation: hospital outcome and risk factor analysis.

 

Overall

(N = 180)

TA-TAVI

(N = 90)

TF-TAVI

(N = 90)

p

Mean age (years)

82 ± 8.6

80 ± 8.5

83 ± 8.4

0.014

Men

82 (46%)

45 (50%)

37 (41%)

0.231a

COPD

38 (21%)

29 (32%)

9 (10%)

<0.001a

Peripheral vascular disease

91 (51%)

71 (79%)

20 (22%)

<0.001a

Previous vascular surgery

17 (9%)

13 (14%)

4 (4%)

0.039

Coronary disease

90 (50%)

54 (60%)

36 (40%)

0.007a

Previous coronary surgery

27 (15%)

19 (21%)

8 (9%)

0.022a

Previous cardiac surgery

40 (22%)

25 (28%)

15 (17%)

0.073a

Previous coronary angioplasty/stenting

28 (16%)

13 (14%)

15 (17%)

0.681a

Hypertension

117 (65%)

56 (62%)

61 (68%)

0.435a

Chronic renal failure

75 (42%)

38 (42%)

37 (41%)

0.880a

Dialysis

7 (4%)

4 (4%)

3 (3%)

1

Previous stroke

20 (11%)

11 (12%)

9 (10%)

0.635a

Diabetes (insulin)

30 (17%)

18 (20%)

12 (13%)

0.230a

Liver disease (CHILD score)

5 (3%)

3 (3%)

2 (2%)

1

pacemaker implantation

21 (12%)

9 (10%)

12 (13%)

0.486a

Chest radiotherapy

16 (9%)

7 (8%)

9 (10%)

0.600a

Preoperative critical state

15 (8%)

13 (14%)

2 (2%)

0.005

Porcelain aorta

12 (13%)

12 (13%)

0 (0%)

1

logistic Euro-SCORE (%)

31 ± 16

36 ± 15

25 ± 14

<0.001

  1. Data presented as mean ± SD or N (%)
  2. a Chi2 value, otherwise it’s a Fischer test or a T-Test value
  3. COPD Chronic Obstructive Pulmonary Disease